Mitochondrial dysfunction and migraine

Evidence and hypotheses

M. Sparaco, M. Feleppa, Richard B. Lipton, A. M. Rapoport, M. E. Bigal

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The molecular basis of migraine is still not completely understood. An impairment of mitochondrial oxidative metabolism might play a role in the pathophysiology of this disease, by influencing neuronal information processing. Biochemical assays of platelets and muscle biopsies performed in migraine sufferers have shown a decreased activity of the respiratory chain enzymes. Studies with phosphorus magnetic resonance spectroscopy (31P-MRS) have demonstrated an impairment of the brain oxidative energy metabolism both during and between migraine attacks. However, molecular genetic studies have not detected specific mitochondrial DNA (mtDNA) mutations in patients with migraine, although other studies suggest that particular genetic markers (i.e. neutral polymorphisms or secondary mtDNA mutations) might be present in some migraine sufferers. Further studies are still needed to clarify if migraine is associated with unidentified mutations on the mtDNA or on nuclear genes that code mitochondrial proteins. In this paper, we review morphological, biochemical, imaging and genetic studies which bear on the hypothesis that migraine may be related to mitochondrial dysfunction at least in some individuals.

Original languageEnglish (US)
Pages (from-to)361-372
Number of pages12
JournalCephalalgia
Volume26
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Migraine Disorders
Mitochondrial DNA
Mutation
Molecular Biology
Mitochondrial Proteins
Electron Transport
Automatic Data Processing
Genetic Markers
Phosphorus
Energy Metabolism
Magnetic Resonance Spectroscopy
Blood Platelets
Biopsy
Muscles
Brain
Enzymes
Genes

Keywords

  • Brain oxidative metabolism
  • Magnetic resonance spectroscopy
  • Migraine
  • Mitochondrial dysfunction
  • Mutation

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Mitochondrial dysfunction and migraine : Evidence and hypotheses. / Sparaco, M.; Feleppa, M.; Lipton, Richard B.; Rapoport, A. M.; Bigal, M. E.

In: Cephalalgia, Vol. 26, No. 4, 04.2006, p. 361-372.

Research output: Contribution to journalArticle

Sparaco, M, Feleppa, M, Lipton, RB, Rapoport, AM & Bigal, ME 2006, 'Mitochondrial dysfunction and migraine: Evidence and hypotheses', Cephalalgia, vol. 26, no. 4, pp. 361-372. https://doi.org/10.1111/j.1468-2982.2005.01059.x
Sparaco, M. ; Feleppa, M. ; Lipton, Richard B. ; Rapoport, A. M. ; Bigal, M. E. / Mitochondrial dysfunction and migraine : Evidence and hypotheses. In: Cephalalgia. 2006 ; Vol. 26, No. 4. pp. 361-372.
@article{3f261cc99b9444e2a75c00e0c9bfa39c,
title = "Mitochondrial dysfunction and migraine: Evidence and hypotheses",
abstract = "The molecular basis of migraine is still not completely understood. An impairment of mitochondrial oxidative metabolism might play a role in the pathophysiology of this disease, by influencing neuronal information processing. Biochemical assays of platelets and muscle biopsies performed in migraine sufferers have shown a decreased activity of the respiratory chain enzymes. Studies with phosphorus magnetic resonance spectroscopy (31P-MRS) have demonstrated an impairment of the brain oxidative energy metabolism both during and between migraine attacks. However, molecular genetic studies have not detected specific mitochondrial DNA (mtDNA) mutations in patients with migraine, although other studies suggest that particular genetic markers (i.e. neutral polymorphisms or secondary mtDNA mutations) might be present in some migraine sufferers. Further studies are still needed to clarify if migraine is associated with unidentified mutations on the mtDNA or on nuclear genes that code mitochondrial proteins. In this paper, we review morphological, biochemical, imaging and genetic studies which bear on the hypothesis that migraine may be related to mitochondrial dysfunction at least in some individuals.",
keywords = "Brain oxidative metabolism, Magnetic resonance spectroscopy, Migraine, Mitochondrial dysfunction, Mutation",
author = "M. Sparaco and M. Feleppa and Lipton, {Richard B.} and Rapoport, {A. M.} and Bigal, {M. E.}",
year = "2006",
month = "4",
doi = "10.1111/j.1468-2982.2005.01059.x",
language = "English (US)",
volume = "26",
pages = "361--372",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Mitochondrial dysfunction and migraine

T2 - Evidence and hypotheses

AU - Sparaco, M.

AU - Feleppa, M.

AU - Lipton, Richard B.

AU - Rapoport, A. M.

AU - Bigal, M. E.

PY - 2006/4

Y1 - 2006/4

N2 - The molecular basis of migraine is still not completely understood. An impairment of mitochondrial oxidative metabolism might play a role in the pathophysiology of this disease, by influencing neuronal information processing. Biochemical assays of platelets and muscle biopsies performed in migraine sufferers have shown a decreased activity of the respiratory chain enzymes. Studies with phosphorus magnetic resonance spectroscopy (31P-MRS) have demonstrated an impairment of the brain oxidative energy metabolism both during and between migraine attacks. However, molecular genetic studies have not detected specific mitochondrial DNA (mtDNA) mutations in patients with migraine, although other studies suggest that particular genetic markers (i.e. neutral polymorphisms or secondary mtDNA mutations) might be present in some migraine sufferers. Further studies are still needed to clarify if migraine is associated with unidentified mutations on the mtDNA or on nuclear genes that code mitochondrial proteins. In this paper, we review morphological, biochemical, imaging and genetic studies which bear on the hypothesis that migraine may be related to mitochondrial dysfunction at least in some individuals.

AB - The molecular basis of migraine is still not completely understood. An impairment of mitochondrial oxidative metabolism might play a role in the pathophysiology of this disease, by influencing neuronal information processing. Biochemical assays of platelets and muscle biopsies performed in migraine sufferers have shown a decreased activity of the respiratory chain enzymes. Studies with phosphorus magnetic resonance spectroscopy (31P-MRS) have demonstrated an impairment of the brain oxidative energy metabolism both during and between migraine attacks. However, molecular genetic studies have not detected specific mitochondrial DNA (mtDNA) mutations in patients with migraine, although other studies suggest that particular genetic markers (i.e. neutral polymorphisms or secondary mtDNA mutations) might be present in some migraine sufferers. Further studies are still needed to clarify if migraine is associated with unidentified mutations on the mtDNA or on nuclear genes that code mitochondrial proteins. In this paper, we review morphological, biochemical, imaging and genetic studies which bear on the hypothesis that migraine may be related to mitochondrial dysfunction at least in some individuals.

KW - Brain oxidative metabolism

KW - Magnetic resonance spectroscopy

KW - Migraine

KW - Mitochondrial dysfunction

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=33645123748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645123748&partnerID=8YFLogxK

U2 - 10.1111/j.1468-2982.2005.01059.x

DO - 10.1111/j.1468-2982.2005.01059.x

M3 - Article

VL - 26

SP - 361

EP - 372

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 4

ER -